‘Experience the difference’ with new formulation maropitant from Dechra

Dechra Veterinary Products is inviting veterinary professionals to ‘Experience the difference’ following the launch of its new formulation anti-emetic injection, Prevomax®.


Prevomax 10 mg/ml is used for the treatment and prevention of vomiting and nausea in dogs and cats.


It contains benzyl alcohol, a preservative that is known to reduce pain at the injection site, compared to the alternative maropitant injection that is preserved by metacresol.


The convenient 20 ml bottle has a 56-day broached shelf life making it ideal for use in busy practice across multiple patients and reduces wastage.


Dechra Brand Manager Claire Morgan said: “We are delighted to launch Prevomax to the UK and IE market.


“Human clinical studies have shown that an injection containing benzyl alcohol causes less pain than an injection preserved with metacresol.


“Prevomax is particularly useful for the treatment and prevention of nausea induced by chemotherapy and for treatment of vomiting, in combination with other supportive measures.
Dechra is inviting veterinary professionals to share their experience of using Prevomax for a chance to win a £100 Amazon gift card.


Entries must be received by February 28 2018 and should be submitted at www.dechra.co.uk/prevomax